"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
1
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
1:00:23
1:00:23
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:23
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.بقلم Timmerman Report
…
continue reading
1
Ep167: Leslie Williams on transfer RNA therapies
1:11:28
1:11:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:11:28
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.بقلم Timmerman Report
…
continue reading
1
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
1:03:35
1:03:35
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:35
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.بقلم Timmerman Report
…
continue reading
1
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
1:02:45
1:02:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:45
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.بقلم Timmerman Report
…
continue reading
1
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
56:39
56:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:39
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.بقلم Timmerman Report
…
continue reading
1
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
1:08:19
1:08:19
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:19
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.بقلم Timmerman Report
…
continue reading
1
Ep162: Sean McClain on AI for Biologic Drug Discovery
1:05:59
1:05:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:59
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep161: Jeff Stein on a Long-Lasting Flu Drug
1:08:51
1:08:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:51
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.بقلم Timmerman Report
…
continue reading
1
Ep160: Abe Ceesay on Precision Neuroscience
1:08:48
1:08:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:48
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
1:07:22
1:07:22
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:07:22
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.بقلم Timmerman Report
…
continue reading
1
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
1:00:44
1:00:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:44
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.بقلم Timmerman Report
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.بقلم Timmerman Report
…
continue reading
1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
1:02:37
1:02:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.بقلم Timmerman Report
…
continue reading
1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
1:03:14
1:03:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.بقلم Timmerman Report
…
continue reading
1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
1:01:43
1:01:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep152: Jens Eckstein on Investing in Healthy Aging
1:05:05
1:05:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.بقلم Timmerman Report
…
continue reading
1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
1:03:55
1:03:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.بقلم Timmerman Report
…
continue reading
1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
1:03:48
1:03:48
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep149: Nancy Stagliano on Precision Neuroscience
1:01:53
1:01:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep148: Diana Brainard on the Fight Against Infectious Disease
1:03:27
1:03:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.بقلم Timmerman Report
…
continue reading
1
Ep147: Reid Huber on Investing in the Future of Medicine
1:08:41
1:08:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.بقلم Timmerman Report
…
continue reading
1
Ep146: Jeff Huber on Life in Tech and Biotech
1:47:05
1:47:05
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.بقلم Timmerman Report
…
continue reading
1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
1:06:39
1:06:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.بقلم Timmerman Report
…
continue reading
1
Ep144: Turning the Tables, Rob Perez Interviews Me
1:04:58
1:04:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:04:58
Turning the Tables, Rob Perez Interviews Meبقلم Timmerman Report
…
continue reading
1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
1:10:25
1:10:25
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:10:25
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech Foundersبقلم Timmerman Report
…
continue reading
1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
55:54
55:54
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.بقلم Timmerman Report
…
continue reading
1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
1:09:30
1:09:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.بقلم Timmerman Report
…
continue reading
1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
1:02:40
1:02:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.بقلم Timmerman Report
…
continue reading
1
Ep139: Kevin Conroy on Early Detection of Cancer
1:08:28
1:08:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.بقلم Timmerman Report
…
continue reading
1
Ep138: Jodie Morrison on Becoming a Biotech CEO
1:00:17
1:00:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.بقلم Timmerman Report
…
continue reading
1
Ep137: Aaron Ring on Immunotherapy for Cancer & More
56:37
56:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.بقلم Timmerman Report
…
continue reading
1
Ep136: Deborah Palestrant on Building Biotech Startups
52:52
52:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.بقلم Timmerman Report
…
continue reading
1
Ep135: John Maraganore on Developing a New Class of Medicines
1:03:51
1:03:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.بقلم Timmerman Report
…
continue reading
1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
1:16:22
1:16:22
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.بقلم Timmerman Report
…
continue reading
1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
1:10:33
1:10:33
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.بقلم Timmerman Report
…
continue reading
1
Ep132: Eric Dobmeier on Treating Kidney Disease
1:05:44
1:05:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.بقلم Timmerman Report
…
continue reading
1
Ep131: Ryan Watts on Neuroscience Drug R&D
1:05:32
1:05:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.بقلم Timmerman Report
…
continue reading
1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
1:09:29
1:09:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.بقلم Timmerman Report
…
continue reading
1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
1:11:43
1:11:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.بقلم Timmerman Report
…
continue reading
1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1:00:34
1:00:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.بقلم Timmerman Report
…
continue reading
1
Ep127: Jeb Keiper on Computational Drug Discovery
1:09:41
1:09:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.بقلم Timmerman Report
…
continue reading
1
Ep126: DA Wallach on Becoming a Biotech VC
1:11:38
1:11:38
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.بقلم Timmerman Report
…
continue reading
1
Ep125: Barry Greene on a New Drug for Depression
1:04:52
1:04:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.بقلم Timmerman Report
…
continue reading
1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
1:09:53
1:09:53
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.بقلم Timmerman Report
…
continue reading
1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
1:15:26
1:15:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.بقلم Timmerman Report
…
continue reading
1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
1:00:04
1:00:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.بقلم Timmerman Report
…
continue reading
1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
1:03:49
1:03:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.بقلم Timmerman Report
…
continue reading
1
Ep120: Tim Lu on Gene Circuits for Cell Therapy
1:04:14
1:04:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.بقلم Timmerman Report
…
continue reading
1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
1:02:42
1:02:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.بقلم Timmerman Report
…
continue reading